Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells

Oncology Reports

Volumn 25, Issue 1, 2011, Pages 273-279

  Wendler, Alexandra ^a   Keller, Daniela ^a   Albrecht, Christian ^a   Peluso, John J ^b   Wehling, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Let 7 miR 98; microRNA; Ovarian cancer; Progesterone; Progesterone receptor membrane component 1

Indexed keywords

ISOPROTEIN; LUCIFERASE; MICRORNA; PROGESTERONE; PROGESTERONE RECEPTOR;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL STIMULATION; COMPUTER MODEL; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MICRORNAS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 78650733528     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00001071     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007
2. Agarwal R and Kaye SB: Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3: 502-516, 2003.
3. Peluso JJ, Liu X, Saunders MM, Claffey KP and Phoenix K: Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J Clin Endocrinol Metab 93: 1592-1599, 2008.
4. Crudden G, Loesel R and Craven RJ: Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors. Tumour Biol 26: 142-146, 2005.
5. Ahmed IS, Rohe HJ, Twist KE, Mattingly MN and Craven RJ: Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule. J Pharmacol Exp Ther 333: 564-573, 2010.
6. Peluso JJ, Gawkowska A, Liu X, Shioda T and Pru JK: Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice. Endocrinology 150: 4846-4854, 2009.
7. Rohe HJ, Ahmed IS, Twist KE and Craven RJ: PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacol Ther 121: 14-19, 2009.
8. Crudden G, Chitti RE and Craven RJ: Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs. J Pharmacol Exp Ther 316: 448-455, 2006.
9. Mallory JC, Crudden G, Oliva A, Saunders C, Stromberg A and Craven RJ: A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells. Mol Pharmacol 68: 1747-1756, 2005.
10. Franco S, Canela A, Klatt P and Blasco MA: Effectors of mammalian telomere dysfunction: a comparative transcriptome analysis using mouse models. Carcinogenesis 26: 1613-1626, 2005.
11. Griffiths-Jones S: miRBase: the microRNA sequence database. Methods Mol Biol 342: 129-138, 2006.
12. Metias SM, Lianidou E and Yousef GM: MicroRNAs in clinical oncology: at the crossroads between promises and problems. J Clin Pathol 62: 771-776, 2009.
13. Ace CI and Okulicz WC: Microarray profiling of progesteroneregulated endometrial genes during the rhesus monkey secretory phase. Reprod Biol Endocrinol 2: 54, 2004.
14. Krebs CJ, Jarvis ED, Chan J, Lydon JP, Ogawa S and Pfaff DW: A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors. Proc Natl Acad Sci USA 97: 12816-12821, 2000.
15. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
16. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105, 2007.
17. Friedman RC, Farh KK, Burge CB and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
18. Betel D, Wilson M, Gabow A, Marks DS and Sander C: The microRNA.org resource: targets and expression. Nucleic Acids Res 36: D149-D153, 2008.
19. John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS: Human MicroRNA targets. PLoS Biol 2: e363, 2004.
20. Wang X: miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14: 1012-1017, 2008.
21. Wang X and El Naqa IM: Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24: 325-332, 2008.
22. Dahiya N, Sherman-Baust CA, Wang TL, et al: MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 3: e2436, 2008.
23. Yang N, Kaur S, Volinia S, et al: MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 68: 10307-10314, 2008.
24. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005.
25. Iorio MV, Visone R, Di Leva G, et al: MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707, 2007.
26. Shell S, Park SM, Radjabi AR, et al: Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 104: 11400-11405, 2007.
27. Dong Q, Meng P, Wang T, et al: MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS One 5: e10147, 2010.
28. Nam EJ, Yoon H, Kim SW, et al: MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695, 2008.
29. Johnson SM, Grosshans H, Shingara J, et al: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
30. Lee YS and Dutta A: The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030, 2007.
31. Johnson CD, Esquela-Kerscher A, Stefani G, et al: The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67: 7713-7722, 2007.
32. Esquela-Kerscher A, Trang P, Wiggins JF, et al: The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7: 759-764, 2008.
33. Losel RM, Besong D, Peluso JJ and Wehling M: Progesterone receptor membrane component 1 -many tasks for a versatile protein. Steroids 73: 929-934, 2008.
34. Zhang L, Kanda Y, Roberts DJ, et al: Expression of progesterone receptor membrane component 1 and its partner serpine 1 mRNA binding protein in uterine and placental tissues of the mouse and human. Mol Cell Endocrinol 287: 81-89, 2008.
35. Kuokkanen S, Chen B, Ojalvo L, Benard L, Santoro N and Pollard JW: Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod 82: 791-801, 2010.
36. Bhat-Nakshatri P, Wang G, Collins NR, et al: Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37: 4850-4861, 2009.
37. Keith Bechtel M and Bonavida B: Inhibitory effects of 17betaestradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase. Gynecol Oncol 82: 127-138, 2001.
38. Markman M: Hormonal therapy of endometrial cancer. Eur J Cancer 41: 673-675, 2005.